Abstract
Protein crystallography is the main technique used to obtain three-dimensional information for binary complexes involving protein and drugs. Once a protein target has its three-dimensional structure elucidated, the next natural step is the solving of the structure complexed either with its natural substrate, or any ligand or even an inhibitor. Such information is of pivotal importance to understand the structural basis for inhibition of an enzyme. The relevant features, for application of protein crystallography to drug discovery, are discussed in this review.
Keywords: Protein, Crystallography, Drug Discovery, three-dimensional structure, natural substrate, ligand, enzyme, inhibitor
Current Drug Targets
Title: Protein Crystallography in Drug Discovery
Volume: 9 Issue: 12
Author(s): Fernanda Canduri and Walter Filgueira de Azevedo Jr.
Affiliation:
Keywords: Protein, Crystallography, Drug Discovery, three-dimensional structure, natural substrate, ligand, enzyme, inhibitor
Abstract: Protein crystallography is the main technique used to obtain three-dimensional information for binary complexes involving protein and drugs. Once a protein target has its three-dimensional structure elucidated, the next natural step is the solving of the structure complexed either with its natural substrate, or any ligand or even an inhibitor. Such information is of pivotal importance to understand the structural basis for inhibition of an enzyme. The relevant features, for application of protein crystallography to drug discovery, are discussed in this review.
Export Options
About this article
Cite this article as:
Canduri Fernanda and de Azevedo Jr. Filgueira Walter, Protein Crystallography in Drug Discovery, Current Drug Targets 2008; 9 (12) . https://dx.doi.org/10.2174/138945008786949423
DOI https://dx.doi.org/10.2174/138945008786949423 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors
Current Diabetes Reviews Sample Size Estimation for Negative Binomial Regression Models with Distinct Shape Parameters
Applied Clinical Research, Clinical Trials and Regulatory Affairs From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Nutrigenomics and Its Approaches for Control of Chronic Diseases
Current Biotechnology Curcumin Reverts the Protein Differential Expression in the Liver of the Diabetic Obese db/db Mice
Current Proteomics An Association between MicroRNA-21 Expression and Vitamin D Deficiency in Coronary Artery Disease
MicroRNA Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
Current Medicinal Chemistry Primary and Secondary Stroke Prevention with Antiplatelet Drugs
Current Pharmaceutical Design Role of Nanotechnology in Diabetic Management
Recent Patents on Nanotechnology Systematic Review of Glucagon-Like Peptide One Receptor Agonist Liraglutide of Subjects with Heart Failure with Reduced Left Ventricular Ejection Fraction
Current Diabetes Reviews Pleiotropic Effects of ARB in Diabetes Mellitus
Current Vascular Pharmacology Rimonabant for the Treatment of Obesity
Recent Patents on Cardiovascular Drug Discovery Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets The Association of Folic Acid Deficiency and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model
Endocrine, Metabolic & Immune Disorders - Drug Targets TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
Current Medicinal Chemistry A Systematic Approach to Assess the Burden of Drug Interactions in Adult Kidney Transplant Patients
Current Drug Safety The Role of Carbonic Anhydrase in Hepatic Glucose Production
Current Diabetes Reviews Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes
Current HIV Research Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Current Pharmaceutical Design